The groundbreaking approach of this peptide represents a major breakthrough in the handling of type 2 diabetes. Distinct from existing therapies, tirzepatide affects multiple pathways – GLP-1 and GIP – leading to https://tirzepatidepeptide797370.smblogsites.com/42105376/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment